Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $64.4B | +$745M | 128 | 1.24% | Increased |
|
| 2 |
BlackRock
New York
| $58.1B | +$2.24B | 139 | 1.31% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $29.2B | -$205M | 124 | 1.28% | Reduced |
|
| 4 |
Fidelity Investments
Boston,
Massachusetts
| $29.1B | -$130M | 103 | 1.87% | Reduced |
|
| 5 |
JP Morgan Chase
New York
| $16.4B | +$758M | 131 | 1.34% | Increased |
|
| 6 |
Capital World Investors
Los Angeles,
California
| $15.9B | -$2.3B | 13 | 2.6% | Reduced |
|
| 7 |
Morgan Stanley
New York
| $15.4B | -$655M | 146 | 1.19% | Reduced |
|
| 8 |
T. Rowe Price Associates
Baltimore,
Maryland
| $15.2B | +$247M | 84 | 1.82% | Increased |
|
| 9 |
Wellington Management Group
Boston,
Massachusetts
| $14.8B | -$1.03B | 58 | 2.64% | Reduced |
|
| 10 |
Geode Capital Management
Boston,
Massachusetts
| $14.4B | +$247M | 142 | 1.26% | Increased |
|
| 11 |
Capital International Investors
Los Angeles,
California
| $10.3B | +$831M | 11 | 2.11% | Increased |
|
| 12 |
Norges Bank
Oslo,
Norway
| $8.94B | +$6.06M | 40 | 1.34% | Increased |
|
| 13 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $8.89B | +$817M | 21 | 5.61% | Increased |
|
| 14 |
Bank of America
Charlotte,
North Carolina
| $8.19B | +$453M | 144 | 0.72% | Increased |
|
| 15 |
Franklin Resources
San Mateo,
California
| $7.92B | +$478M | 50 | 2.43% | Increased |
|
| 16 |
Capital Research Global Investors
Los Angeles,
California
| $7.75B | +$243M | 7 | 1.7% | Increased |
|
| 17 |
Massachusetts Financial Services
Boston,
Massachusetts
| $7.08B | -$32.9M | 23 | 2.18% | Reduced |
|
| 18 |
Northern Trust
Chicago,
Illinois
| $6.96B | -$6.13M | 122 | 1.17% | Reduced |
|
| 19 |
Bank of New York Mellon
New York
| $6.71B | +$72.3M | 95 | 1.27% | Increased |
|
| 20 |
Goldman Sachs
New York
| $5.64B | +$1.11B | 107 | 0.95% | Increased |
|
| 21 |
UBS AM
Chicago,
Illinois
| $4.75B | +$1.3B | 56 | 1.36% | Increased |
|
| 22 |
Invesco
Atlanta,
Georgia
| $4.69B | -$15.2M | 82 | 0.99% | Reduced |
|
| 23 |
Dodge & Cox
San Francisco,
California
| $4.67B | -$59.6M | 5 | 2.81% | Reduced |
|
| 24 |
Dimensional Fund Advisors
Austin,
Texas
| $4.67B | +$226M | 73 | 1.22% | Increased |
|
| 25 |
Janus Henderson Group
London,
| $4.42B | -$854M | 60 | 2.37% | Reduced |
|